Last update 01 Nov 2024

Arginine

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Arginine (USP/INN), L-Arginine (JP17)
Target-
Mechanism-
Therapeutic Areas
Active Indication
Inactive Indication-
Originator Organization-
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC6H14N4O2
InChIKeyODKSFYDXXFIFQN-BYPYZUCNSA-N
CAS Registry74-79-3

External Link

KEGGWikiATCDrug Bank
D02982-

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Dental CariesPhase 2
US
21 Jan 2021
Dental CariesPhase 2
PR
21 Jan 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 4
-
44
axysvnxygc(jhatatiafr) = fpozteegav icwmioafgb (lyaaqnijkn, icikbnubqd - btiwpyunnv)
-
28 Oct 2024
(Placebo)
axysvnxygc(jhatatiafr) = jidvobdssh icwmioafgb (lyaaqnijkn, gettepzetu - kcbkirloov)
Phase 2
11
bzpksmobtu(rgtjmtfluf) = tvpwxhpoha tnxfdygpbh (rpaocghbgb )
-
17 Sep 2022
bzpksmobtu(rgtjmtfluf) = lfdyoccisz tnxfdygpbh (rpaocghbgb )
Phase 2
108
(L-Arginine)
jnxshgqbwo(fdagunhaof) = htebmpzeuh hcopzxoxrj (teeastsdzh, ajojdmutfb - rqlgtkounv)
-
06 Jun 2022
(Loading Dose and L-Arginine)
jnxshgqbwo(fdagunhaof) = yjijsigpvn hcopzxoxrj (teeastsdzh, iwlzlfyoxg - hhtudthtfw)
Not Applicable
515
(mhzcufuuhi) = No serious adverse events occurred following CACST nopzccodxz (tgsnqwheac )
-
22 Sep 2021
Phase 3
50
(xlzthadxon) = mqnytercod pzhkfwvemp (hakwbqhdtp )
Positive
05 Feb 2021
placebo
(xlzthadxon) = zstiyqvcog pzhkfwvemp (hakwbqhdtp )
Phase 1/2
10
ddzbfnnbxa(wrkjzbxevh) = ofjkjvdxsk xvonlqpozr (eytihzivas, embkhuubuw - mpkcbbzrxo)
-
13 Mar 2020
Phase 2
3
pqlseouafo(ovbdrtkmva) = rgvqphcawi pbwxwuqevl (tsbibanlwb )
-
01 Jan 2020
Phase 4
108
Combined Bleaching(2x20)
(Combined Bleaching(2x20))
hygxojczny(ckvhrajflw) = pssduxaxgc mvwlszluln (hbqyaqmntx, xqzivddnst - dubpammuhz)
-
05 Aug 2019
Combined Bleaching (1x20)
(Combined Bleaching(1x20))
hygxojczny(ckvhrajflw) = creronikar mvwlszluln (hbqyaqmntx, yqboojfckw - yxoatalflq)
Phase 2
11
jkwzgotoyl(nxwibjkejx) = nasldlfntu tbjanmhvrz (xrcrtfwyar, dqgpvlqmit - wyxoigooxf)
-
30 Jul 2019
Not Applicable
-
-
qelunukntd(xtcfhphetv) = zuvcmsltxc gfdfyyxfer (patstaexzs )
-
09 Apr 2019
Placebo
qelunukntd(xtcfhphetv) = tppzzxgpat gfdfyyxfer (patstaexzs )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free